Showing results (61-70 of 173) with videos related to
Sort By:
Pageof 18
Diabetes Care|September 4, 1998
Troglitazone use in insulin-treated type 2 diabetic patients. The Troglitazone Insulin Study GroupJ B Buse, B Gumbiner, N P Mathias, et al.Medicine and Science in Sports and Exercise|August 28, 2010
Physical activity and hypertensive disorders of pregnancy among Hispanic womenRenée Turzanski Fortner, Penelope S Pekow, Brian W Whitcomb, et al.The Journal of Clinical Endocrinology and Metabolism|September 11, 1991
Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient menJ S Finkelstein, R W Whitcomb, L S O'Dea, et al.American Journal of Epidemiology|November 26, 2015
Premenstrual Syndrome and Subsequent Risk of Hypertension in a Prospective StudyElizabeth R Bertone-Johnson, Brian W Whitcomb, Janet W Rich-Edwards, et al.American Journal of Preventive Medicine|November 20, 2012
Inflammation and early-life abuse in womenElizabeth R Bertone-Johnson, Brian W Whitcomb, Stacey A Missmer, et al.Journal of Cancer Survivorship : Research and Practice|March 8, 2017
Validity of self-reported fertility-threatening cancer treatments in female young adult cancer survivorsSamantha C Roberts, Amber Knight, Brian W Whitcomb, et al.Journal of Cancer Survivorship : Research and Practice|May 27, 2014
Factors associated with pregnancy attempts among female young adult cancer survivorsSally A Dominick, Brian W Whitcomb, Jessica R Gorman, et al.Endocrinology|October 11, 1991
Precursors of alpha-inhibin modulate follicle-stimulating hormone receptor binding and biological activityA L Schneyer, P M Sluss, R W Whitcomb, et al.Journal of Adolescent and Young Adult Oncology|July 22, 2017
Age and Cancer Treatment Are Related to Receiving Treatment Summaries and Survivorship Care Plans in Female Young Adult Cancer SurvivorsKsenya Shliakhtsitsava, Sally A D Romero, Brian W Whitcomb, et al.Obstetrics and Gynecology|October 1, 1996
Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptomsL Speroff, R W Whitcomb, N J Kempfert, et al.Pageof 18